Publications by authors named "Kenna D Payne"

Claim this Profile
D
Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options).
Kenna D Payne, Amrita Das, Michelle Ndiulor, Ronald G Hall

Expert Rev Clin Pharmacol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options).
Ronald G Hall, Michael Thatcher, Wei Wei, Shibin Varghese, Lincy Varughese, Kenna D Payne

Expert Rev Clin Pharmacol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing of antifungal agents in obese people.
Kenna D Payne, Ronald G Hall

Expert Rev Anti Infect Ther· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing of antibacterial agents in obese adults: does one size fit all?
Kenna D Payne, Ronald G Hall

Expert Rev Anti Infect Ther· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A standardized patient counseling rubric for a pharmaceutical care and communications course.
Niambi Horton, Kenna D Payne, Michelle Jernigan, Jill Frost, Stephen Wise

Am J Pharm Educ· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy.
Anita P Rahman, Susan A Eaton, Sean T Nguyen, Amy M Bain, Kenna D Payne

Pharmacotherapy· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter evaluation of vancomycin dosing: emphasis on obesity.
Ronald G Hall, Kenna D Payne, Amy M Bain, Anita P Rahman, Sean T Nguyen

Am J Med· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
Sean T Nguyen, Susan A Eaton, Amy M Bain, Anita P Rahman, Kenna D Payne

Pharmacotherapy· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis